Results
1 -
6 of
6Therapeutic Implications of the Unusually Long Half-Life of (E)-5-(2-BRO-Movinyl)Uracil (BVUra) in Vivo, Frontiers in Microbiology Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2u2032-deoxyuridine, Journal of Cancer Research and Clinical Oncology Microbiological synthesis of 5-ethyl- and (E)-5-(2-bromovinyl)-2u2032-deoxyuridine, Biotechnology Letters Pharmacological considerations of antiviral agents, IUPHAR 9th International Congress of Pharmacology London 1984 The Modulation of Drug Efficacy and Toxicity by the Gut Microbiome, Metabonomics and Gut Microbiota in Nutrition and Disease Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances [Online], Thieme: Stuttgart, (2006)..
Brivudine, Pharmaceutical Substances